.png)
According to the report by Expert Market Research (EMR), the Global Tinea Corporis Treatment Market Size is being aided by the growing antifungal drugs market, which is expected to grow at a CAGR of 3% in the forecast period of 2023-2028. Aided by the rising incidence of fungal infections and the broadening range of treatment options for Tinea Corporis, the market is expected to grow significantly by 2028.
Tinea Corporis, commonly known as ringworm, is a fungal infection that primarily affects the skin. Its treatment often involves antifungal medications, which are available in various forms, such as creams, lotions, powders, and tablets. These medications not only help in eliminating the infection but also alleviate associated symptoms like itching and redness. Aside from their therapeutic benefits, some antifungal drugs also exhibit preventive properties, making them an essential component in the broader dermatological treatment landscape.
Tinea Corporis Treatment Market Size, Share, Price, Trends, Growth, Key Players, Report and Forecast
The escalating global incidence of fungal infections is a significant driver for the tinea corporis treatment market growth. With the expanding global population and increased exposure to risk factors such as public showers and locker rooms, there has been a marked rise in the prevalence of Tinea Corporis. This has spurred demand for effective treatments, benefiting the overall market. Additionally, increased awareness about personal hygiene and skin health has further contributed to the demand for Tinea Corporis treatments.
The expanding range of Tinea Corporis treatment options also plays a substantial role in stimulating tinea corporis treatment market development. The pharmaceutical industry has witnessed the introduction of several new antifungal drugs with improved efficacy and fewer side effects. The cosmetic industry has also leveraged these advancements, incorporating antifungal ingredients into various skincare products, thus widening their application range. Moreover, innovations in drug delivery systems, such as the development of long-acting topical formulations, have added a new dimension to the Tinea Corporis treatment market.
Get a Free Sample Report with Table of Contents – https://www.expertmarketresearch.com/reports/tinea-corporis-treatment-market/requestsample
Moreover, the growing focus on over-the-counter (OTC) treatments in the pharmaceutical industry has amplified the importance of antifungal medications as viable treatment options for Tinea Corporis. With the ongoing trend of self-medication and the increasing accessibility of OTC products, antifungal medications have become a key element in the global approach to Tinea Corporis treatment, thereby boosting the tinea corporis treatment market expansion.
Tinea Corporis Treatment Market Segmentation
The market can be divided based on drug class, route of administration, distribution channel, and region.
Read Full Report with Table of Contents – https://www.expertmarketresearch.com/reports/tinea-corporis-treatment-market
Market Breakup by Drug Class
- Antifungal
- Steroids
- Anti-Infectives
- Others
Market Breakup by Route of Administration
- Topical
- Oral
Market Breakup by Distribution Channel
- Drug Stores
- Hospital Pharmacies
- Online
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Competitive Landscape
The EMR report looks into the market shares, plant turnarounds, capacities, investments, and acquisitions and mergers, among other major developments, of the global tinea corporis treatment companies. Some of the major key players explored in the report by Expert Market Research are as follows:
- GlaxoSmithKline plc
- Glenmark Pharmaceuticals Limited
- Bayer AG
- Taro Pharmaceutical Industries Ltd.
- Others
About Us
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
Media Contact:
0 Comments:
Post a Comment